Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
Novartis shields eye-drop patent at European Patent Office
Americas
Novartis shields eye-drop patent at European Patent Office
Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company’s application.   19 December 2024
CREATES Act unfairly tips the scales to generics
Americas
CREATES Act unfairly tips the scales to generics
The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.   19 December 2024
LSPN launches its first-ever US awards to celebrate life sciences leaders
Americas
LSPN launches its first-ever US awards to celebrate life sciences leaders
LSIPR’s key event series to host its inaugural ceremony next year in Boston | Spotlight on top innovators and firms in life sciences IP | Gala to honour contributions across 21 categories with 15 judges.   17 December 2024
Americas
Pharma giants seek closure on COVID-19 vaccine rows
Regeneron inks deal over suit concerning a protein for testing COVID-19 treatments | BioNTech aims to resolve university dispute over patented tech used in the Comirnaty vaccine.   17 December 2024
Americas
Foley & Lardner adds litigation and transaction expert in New York
Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings nearly two decades of experience in IP strategy, litigation, and transactions | Experience in biotechnology, medical devices, and blockchain.   12 December 2024
Americas
‘AI curious’ counsel at AZ, Novartis weigh risks and benefits
Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading pharma counsel.   10 December 2024
Americas
Trump’s return sparks calls for pro-patent agenda
As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen.   5 December 2024
Americas
EOFlow ordered to pay rival $452m over insulin patch trade secrets
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.   5 December 2024
Americas
Gilead awarded $30m over counterfeit HIV drug scheme
Wholesaler ‘bought nearly 17,000 bottles of fake Gilead drugs’ | US government says defendant sentenced in September should pay company for lost profits.   26 November 2024
Europe
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
European Patent Office deals blow to pharma companies in dismissing their attempts to reinstate patents covering diabetes and obesity treatments | Inhibrx antibody patent upheld as Gilead subsidiary appeal is rejected.   21 November 2024